Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response to PCV13 and PPSV23 in adults living with HIV
RBR-3qppfyqCompleted
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Apr 2023
- Modality
- Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Trial of pneumococcal 13-valent conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine, sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Apr 2023; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine23-valent pneumococcal polysaccharide vaccine
Beyond the preview
Go deeper on RBR-3qppfyq.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3qppfyq.